Health and effects
Cannabinoids and Subjective sleepiness
What studies can tell us about cannabinoids and Subjective sleepiness, including human research, early evidence, and important limits.
The short answer
What does the research say about Subjective sleepiness?
Researchers have studied cannabinoids in connection with Subjective sleepiness. The current literature covers CBD. This page brings together 2 human-study sources and 1 research review. It includes 3 specific study findings from 3 sources. Human research is included, although its design and scope vary. There is no single answer that applies to every cannabinoid, dose, product, or person. 1
Key takeaways
What to know first
Research areas
What researchers studied about Subjective sleepiness
These are the main questions represented in the current literature. Each link opens a source used to build the overview.
Human research included
CBD
Researchers have studied CBD in connection with Subjective sleepiness. The exact compound, dose, formulation, sleep or health measure, and study design determine what the source can show. 3
Results extracted so far
What did the studies report?
These summaries appear only when the recorded study outcome is specific enough to reproduce from the linked source. If a source has no result summary here, the result has not been extracted yet; that does not mean the study found no effect.
-
In a systematic review and meta-analysis of medical cannabis for adult insomnia involving adults with insomnia across included studies, researchers reported an increase in sleep improvement attributed to 50-to-300-mg CBD doses in an insomnia review following CBD 50 to 300 mg in the favorable review conclusion by the oral or sublingual across included studies route over varied across included studies. The recorded comparator was varied across included studies. 1
Recorded result: The abstract concluded that CBD doses of 50 to 300 mg were safe and effective for improving sleep; it did not report a CBD-specific pooled effect estimate.
-
In a randomized placebo-controlled crossover pilot trial involving 20 adults with DSM-5 insomnia disorder, researchers did not detect a difference in subjective sleep quality after an acute thc-cbd dose following 10 mg THC and 200 mg CBD once by the oral route over single study night. The recorded comparator was placebo. 2
Recorded result: No change in subjective sleep quality was detected.
-
In a randomized placebo-controlled crossover trial involving 64 patients with primary hypertension, researchers reported a decrease in excessive daytime sleepiness in primary hypertension following 225 to 450 mg by the not stated in the PubMed abstract route over 5 weeks per condition. The recorded comparator was placebo. 3
Recorded result: ESS score improved during CBD but not placebo (F=6.738; P=.011).
How strong is the research?
Not every study answers the same question
This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.
Human studies
Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.
Reviews and evidence summaries
Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.
Lab, animal, and mechanism research
Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.
What these studies actually looked at
The research on Subjective sleepiness is not one kind of study. This source set includes 2 clinical studies in people and 1 systematic review or meta-analysis. 3
The recorded populations or models include 20 adults with DSM-5 insomnia disorder (1 source), adults with insomnia across included studies (1 source), and people or patients (1 source). A result from one group or model should not be assumed to apply to another. 1
The most common recorded outcome focus is epworth Sleepiness Scale (1 source), sleep disturbance, daytime sleepiness, total sleep time, and validated insomnia scales (1 source), and subjective sleep quality (1 source). Closely related outcome names can still describe different measurements. 2
Some source records specify doses including 10 mg THC and 200 mg CBD once (1 source), 225 to 450 mg (1 source), and cBD 50 to 300 mg in the favorable review conclusion (1 source). These are descriptions of what researchers tested, not personal dosing instructions. 3
Examples from the literature
What did the studies actually look at?
Each example names the research question and the study details recorded for that source.
systematic review or meta-analysis
Medical cannabis for treatment of insomnia in adults: A systematic review and meta-analysis.
On this page, this source examines CBD and sleep improvement attributed to 50-to-300-mg CBD doses in an insomnia review. 1
- Study type
- systematic review or meta-analysis
- Population or model
- adults with insomnia across included studies
- Outcome focus
- sleep disturbance, daytime sleepiness, total sleep time, and validated insomnia scales
- Dose recorded
- cBD 50 to 300 mg in the favorable review conclusion
- Evidence stage
- systematic review
clinical study in people
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial.
On this page, this source examines CBD and subjective sleep quality after an acute THC-CBD dose. 2
- Study type
- clinical study in people
- Population or model
- 20 adults with DSM-5 insomnia disorder
- Outcome focus
- subjective sleep quality
- Dose recorded
- 10 mg THC and 200 mg CBD once
- Evidence stage
- human research
clinical study in people
Chronic Cannabidiol Administration Mitigates Excessive Daytime Sleepiness and Fatigue in Patients with Primary Hypertension: Insights from a Randomized Crossover Trial.
On this page, this source examines CBD and excessive daytime sleepiness in primary hypertension. 3
- Study type
- clinical study in people
- Population or model
- people or patients
- Outcome focus
- epworth Sleepiness Scale
- Dose recorded
- 225 to 450 mg
- Evidence stage
- human research
Safety and limits
What should readers keep in mind?
Research on Subjective sleepiness should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 2
Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.
Common questions
Questions people ask
Can cannabinoids help with Subjective sleepiness?
Research exists, but there is not one answer for every cannabinoid or product. Human research is included, although its design and scope vary. 1
Why can studies reach different answers?
Studies may test different cannabinoids, doses, formulations, routes, people, and outcomes. Those differences can change the result. 2
What should I check in a study?
Check whether it studied people, what product and dose it used, what it measured, how long it lasted, and whether safety was reported. 3
Sources
Read the research
The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.
-
1
Medical cannabis for treatment of insomnia in adults: A systematic review and meta-analysis. systematic review or meta-analysis; systematic review PubMed 42207928 DOI 10.1097/jxx.0000000000001289
-
2
Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. clinical study in people; human research PubMed 40631525 DOI 10.1111/jsr.70124
-
3
Chronic Cannabidiol Administration Mitigates Excessive Daytime Sleepiness and Fatigue in Patients with Primary Hypertension: Insights from a Randomized Crossover Trial. clinical study in people; human research PubMed 39187263 DOI 10.1089/can.2024.0028
See all 3 research sources
This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.
- Acute Effects of Oral Cannabinoids on Sleep and High-Density EEG in Insomnia: A Pilot Randomised Controlled Trial. clinical study in people; human research / 1 linked research note PubMed 40631525
- Chronic Cannabidiol Administration Mitigates Excessive Daytime Sleepiness and Fatigue in Patients with Primary Hypertension: Insights from a Randomized Crossover Trial. clinical study in people; human research / 1 linked research note PubMed 39187263
- Medical cannabis for treatment of insomnia in adults: A systematic review and meta-analysis. systematic review or meta-analysis; systematic review / 1 linked research note PubMed 42207928